Eyepoint Pharmaceuticals (EYPT) Stock Chart & Stock Price History $9.98 -0.09 (-0.88%) As of 12:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Eyepoint Pharmaceuticals Stock Price Performance The Eyepoint Pharmaceuticals (EYPT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 8.96%, with a year-to-date return of 33.97%. In the past month, the stock has increased 0.31%, reflecting recent market activity. As of the latest close, Eyepoint Pharmaceuticals traded at $10.07 with a market cap of $692.92 million and volume of 785,022 shares. Five years ago, the stock traded at a split-adjusted price of $70.00, representing a 85.74% decrease over that period. At the time, it had a market cap of $81.80 million and a volume of 845,669 shares. Receive EYPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eyepoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.79%1 Month Performance+0.31%3 Month Performance+63.49%Year-To-Date Performance+33.97%1 Year Performance+8.96%5 Year Performance-85.74% EYPT Stock Chart for Friday, August, 8, 2025 EYPT Chart by TradingView Eyepoint Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$10.58$10.07-4.82%$10.81$10.05785,022 shs$692.92 million08/06/2025$10.89$10.58-2.85%$10.73$9.51961,834 shs$728.01 million08/05/2025$10.06$10.89+8.25%$10.92$9.40973,444 shs$749.35 million08/04/2025$9.71$10.06+3.60%$10.10$9.43671,186 shs$692.23 million08/01/2025$9.82$9.71-1.12%$9.89$9.58502,236 shs$668.15 million07/31/2025$9.84$9.82-0.20%$10.18$9.77478,790 shs$675.71 million07/30/2025$9.85$9.84-0.10%$10.41$9.82466,599 shs$677.10 million07/29/2025$10.03$9.85-1.79%$10.23$9.77371,256 shs$677.78 million07/28/2025$10.48$10.03-4.29%$10.57$10.01389,747 shs$690.16 million07/25/2025$10.49$10.48-0.10%$10.52$10.12406,486 shs$721.13 million Get the Latest News and Ratings for EYPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eyepoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$10.70$10.49-1.96%$10.84$10.25531,622 shs$721.83 million07/23/2025$10.45$10.70+2.39%$11.00$10.34523,222 shs$736.27 million07/22/2025$10.54$10.45-0.85%$10.77$10.26627,014 shs$719.06 million07/21/2025$10.42$10.54+1.15%$11.08$10.48749,312 shs$725.27 million07/18/2025$10.30$10.42+1.17%$10.80$10.28725,508 shs$717 million07/17/2025$10.06$10.30+2.39%$10.58$10.00477,477 shs$708.75 million07/16/2025$9.84$10.06+2.24%$10.22$9.79737,645 shs$692.23 million07/15/2025$10.17$9.84-3.24%$10.35$9.70511,928 shs$677.10 million07/14/2025$10.36$10.17-1.83%$10.60$10.16545,471 shs$699.81 million07/11/2025$11.06$10.36-6.33%$11.14$10.27903,298 shs$712.88 million07/10/2025$10.96$11.06+0.91%$11.20$10.70531,097 shs$761.04 million07/09/2025$9.95$10.96+10.15%$11.69$10.001.40 million shs$754.16 million07/08/2025$9.49$9.95+4.85%$10.06$9.601.30 million shs$684.67 million07/07/2025$9.83$9.49-3.50%$9.99$9.45558,039 shs$653.01 million Related Companies TXG Stock Price Chart TRNS Stock Price Chart ALNT Stock Price Chart AEHR Stock Price Chart LAB Stock Price Chart CTKB Stock Price Chart SENS Stock Price Chart QTRX Stock Price Chart QSI Stock Price Chart FEIM Stock Price Chart Receive EYPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eyepoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EYPT) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eyepoint Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eyepoint Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EYPT Stock Alerts